Government at “half way house” in its life sciences plan, says chemistry chief
Plans to revitalise the biomedical industry must be matched by significant investment in drug discovery, according to the chief executive of the Royal Society of Chemistry
07-Dec-2011 -
Dr Robert Parker welcomed the announcement by the prime minister of a £180m biomedical catalyst fund, but was concerned no specific plans have been introduced to capitalise on the UK’s strength in medicinal chemistry.“For this welcome investment to have maximum economic impact, further urgent ...
medicinal chemistry